PreferaOB One description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

PreferaOB One

Alaven Pharmaceutical LLC

PreferaOB ONE


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Prenatal/Postnatal Multivitamin/
Multimineral/DHA softgel

Rx Only

PREFERAOB ONE DESCRIPTION

PreferaOB ONE is a prescription prenatal/postnatal multivitamin/multimineral nutritional supplement with Omega-3 fatty acid (life'sDHA life'sDHA is a trademark of Martek Biosciences Corporation, Columbia, MD.). PreferaOB ONE is an oblong shaped, opaque purple colored softgel, imprinted "AP 86" in white ink on one side and plain on the other.

Each PreferaOB ONE Softgel contains:

Vitamin C (as ascorbic acid) 25 mg
Vitamin D3 (as cholecalciferol) 400 IU
Vitamin E (as dl-alpha tocopheryl acetate) 10 IU
Vitamin B3 (niacin as niacinamide) 17 mg
Vitamin B6 (as pyridoxine HCl) 50 mg
Folic Acid 1 mg
Vitamin B12 (as cyanocobalamin) 12 mcg
Biotin 30 mcg
Vitamin B5 (as d-calcium pantothenate) 10 mg
Iron
 as PIC (polysaccharide iron complex) 22 mg
 as HIP (heme iron polypeptide as
 Proferrin® Proferrin® is a registered trademark of Colorado Biolabs, Inc , Cozad, NE. -bovine source, USDA certified) 6 mg
Iodine (as potassium iodide) 175 mcg
Zinc (as zinc oxide) 15 mg
   
Docosahexaenoic Acid (DHA) 200 mg

DHA is derived from the oils of microalgae, which is grown outside of the ocean, in a controlled environment, eliminating the risk of oceanic contamination.

Inactive Ingredients

Gelatin, soybean oil, yellow beeswax, and lecithin.

PREFERAOB ONE INDICATIONS AND USAGE

PreferaOB ONE is a prescription multivitamin/multimineral nutritional supplement with Omega-3 fatty acid (life'sDHA™) indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. PreferaOB ONE is also beneficial in improving the nutritional status of women prior to conception.

PREFERAOB ONE CONTRAINDICATIONS

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING

Ingestion of more than 3 grams of Omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of Omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding diathesis.

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS

Folic acid when administered as a single agent in doses above 0.1 mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. Pregnant women and nursing mothers should avoid supplemental doses of vitamin E higher than RDA amounts. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.

PREFERAOB ONE ADVERSE REACTIONS

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

PREFERAOB ONE DOSAGE AND ADMINISTRATION

One softgel daily with or without food, or as prescribed by a licensed health care provider with prescribing authority.

HOW SUPPLIED

PreferaOB ONE is supplied in child-resistant blister packs of 30 softgels (NDC 68220-086-30) and as a Professional Sample (NDC 68220-086-25).

KEEP OUT OF REACH OF CHILDREN.

STORAGE

Store at controlled room temperature 20°-25°C (68°-77°F). Excursions permitted to 15°-30°C (59°-86°F). [See current USP]

To protect from light, dispense in carton provided. Once open, blisters should be stored in carton.

For medical inquiries call toll free
1-888-317-0001

www.PreferaOB.com

Manufactured for:
Alaven® Pharmaceutical LLC
Marietta, GA 30062

U.S. Patent No. 7,585,527

PreferaOB® is a registered trademark and PreferaOB ONE is a trademark of Alaven® Pharmaceutical LLC, Marietta, GA.

CL6-086-00-01-1209a

PRINCIPAL DISPLAY PANEL - 30 Softgels Blister Package

Rx Only
NDC 68220-086-30

30 Softgels

PreferaOB ONE

The Prenatal YOU CAN COUNT ON!

FIRST and ONLY prenatal with Natural,
Body-Ready HEME Iron + DHA In
an all-in-one softgel

12 Essential Vitamins
and Minerals including:

- High dose of vitamin B6

- 1mg of folic acid

Plus Plant-based life'sDHA™ Omega-3

Pre/Post-natal Nutritional

Supplement + DHA

life'sDHA™

www.PreferaOB.com

PreferaOB One

PreferaOB One

folic acid, heme iron polypeptide, iron dextran, potassium iodide, zinc oxide, ascorbic acid, cholecalciferol, doconexent, .alpha.-tocopherol acetate, dl-, niacinamide, pyridoxine hydrochloride, cyanocobalamin, biotin and calcium pantothenate capsule CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:68220-086
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
FOLIC ACID FOLIC ACID 1 mg
Heme Iron Polypeptide FERRIC CATION 6 mg
IRON DEXTRAN Ferric Cation 22 mg
Potassium Iodide IODIDE ION 175 ug
Zinc Oxide Zinc oxide 15 ug
ASCORBIC ACID ASCORBIC ACID 25 mg
CHOLECALCIFEROL CHOLECALCIFEROL 400 [iU]
DOCONEXENT DOCONEXENT 200 mg
.ALPHA.-TOCOPHEROL ACETATE, DL- .ALPHA.-TOCOPHEROL, DL- 10 [iU]
NIACINAMIDE 17 mg
PYRIDOXINE HYDROCHLORIDE PYRIDOXINE 50 mg
Cyanocobalamin CYANOCOBALAMIN 12 ug
BIOTIN 30 ug
CALCIUM PANTOTHENATE PANTOTHENIC ACID 10 mg

Inactive Ingredients

Ingredient Name Strength
HYDROGENATED SOYBEAN OIL
WAX, YELLOW
GELATIN
LECITHIN, SOYBEAN

Product Characteristics

Color Size Imprint Code Shape
PURPLE 25 mm AP;86 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:68220-086-05 5 in 1 BLISTER PACK
2 NDC:68220-086-05 5 in 1 BLISTER PACK
3 NDC:68220-086-25 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2010-04-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.